"Designing Growth Strategies is in our DNA"

Australia Equine Health Market Size, Share & Industry Analysis, By Product (Drugs {Anti-Infectives, Anti-Inflammatory, Parasiticides, Others}, Vaccines {Inactivated, Live Attenuated, Recombinant, Others}, Supplemental Feed Additives), By Disease (West Nile Virus, Equine Rabies, Equine Influenza, Equine Herpes Virus, Potomac Horse Fever, Tetanus, Others), By Distribution Channel (Veterinary Hospitals and Clinics, Retail Pharmacies & Drug Stores, Others), and Regional Forecast, 2025-2032

Last Updated: December 15, 2025 | Format: PDF | Report ID: FBI113858

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Statistics: Equine Population, Australia, 2024
    2. Regulatory Scenario, Equine Health, Australia, 2024
    3. Overview: Technological Advancements in Equine Health
    4. Overview: Vaccination Programs for Equines in Australia
    5. Statistics: Stud Farms in Australia
    6. Overview: Current Practices Followed by Veterinarians to Strengthen Equine Health
    7. Key Industry Developments - Mergers, Acquisitions, Partnerships, Launches, etc.
  5. Australia Equine Health Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product
      1. Drug
        1. Anti-Infectives
        2. Anti-Inflammatory
        3. Parasiticides
        4. Others
      2. Vaccine
        1. Inactivated
        2. Live Attenuated
        3. Recombinant
        4. Others
      3. Supplemental Feed Additives
    2. Market Analysis, Insights and Forecast – By Disease
      1. West Nile Virus
      2. Equine Rabies
      3. Equine Influenza
      4. Equine Herpes Virus
      5. Potomac Horse Fever
      6. Tetanus
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Veterinary Hospitals and Clinics
      2. Retail Pharmacies and Drug Stores
      3. Others
  6. Competitive Analysis
    1. Australia Market Share Analysis (2024)
    2. Company Profiles
      1. Boehringer Ingelheim International GmbH.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Elanco
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Zoetis Services LLC.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Ceva
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Virbac
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Vetoquinol
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Abbey Labs
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Merck & Co., Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Purina Animal Nutrition LLC.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Norbrook
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      11. Zamira
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Statistics: Equine Population, Australia, 2024
    2. Regulatory Scenario, Equine Health, Australia, 2024
    3. Overview: Technological Advancements in Equine Health
    4. Overview: Vaccination Programs for Equines in Australia
    5. Statistics: Stud Farms in Australia
    6. Overview: Current Practices Followed by Veterinarians to Strengthen Equine Health
    7. Key Industry Developments - Mergers, Acquisitions, Partnerships, Launches, etc.
  5. Australia Equine Health Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product
      1. Drug
        1. Anti-Infectives
        2. Anti-Inflammatory
        3. Parasiticides
        4. Others
      2. Vaccine
        1. Inactivated
        2. Live Attenuated
        3. Recombinant
        4. Others
      3. Supplemental Feed Additives
    2. Market Analysis, Insights and Forecast – By Disease
      1. West Nile Virus
      2. Equine Rabies
      3. Equine Influenza
      4. Equine Herpes Virus
      5. Potomac Horse Fever
      6. Tetanus
      7. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Veterinary Hospitals and Clinics
      2. Retail Pharmacies and Drug Stores
      3. Others
  6. Competitive Analysis
    1. Australia Market Share Analysis (2024)
    2. Company Profiles
      1. Boehringer Ingelheim International GmbH.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Elanco
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Zoetis Services LLC.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Ceva
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Virbac
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Vetoquinol
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Abbey Labs
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Merck & Co., Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Purina Animal Nutrition LLC.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Norbrook
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      11. Zamira
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Australia Equine Health Market Revenue Breakdown (USD Million, %), By Product, 2024 & 2032

Figure 2: Australia Equine Health Market Value Share (%), by Product, 2024 & 2032

Figure 3: Australia Equine Health Market Value Share (%), by Disease, 2024 & 2032

Figure 4: Australia Equine Health Market Value Share (%), by Distribution Channel, 2024 & 2032

Figure 5: Australia Equine Health Market Share (%), By Company, 2024

Table 1: Australia Equine Health Market Revenue (USD Million) Forecast, by Product, 2019–2032

Table 2: Australia Equine Health Market Revenue (USD Million) Forecast, by Drugs, 2019–2032

Table 3: Australia Equine Health Market Revenue (USD Million) Forecast, by Vaccines, 2019–2032

Table 4: Australia Equine Health Market Revenue (USD Million) Forecast, by Disease, 2019–2032

Table 5: Australia Equine Health Market Revenue (USD Million) Forecast, by Distribution Channel, 2019–2032

Australia Equine Health Market
  • 2019-2032
  • 2024
  • 2019-2023
  • 102
  • Buy Now

    (Offer valid till 15th Jan 2026)

Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports